Qube Research & Technologies (QRT)
MRK icon

Qube Research & Technologies (QRT)’s Merck MRK Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$52.7M Sell
438,100
-369,900
-46% -$42.7M 0.06% 407
2025
Q4 		$85.1M Sell
808,000
-391,700
-33% -$36.8M 0.09% 301
2025
Q3 		$101M Sell
1,199,700
-12,900
-1% -$1.06M 0.1% 239
2025
Q2 		$96M Buy
1,212,600
+171,600
+16% +$13.6M 0.1% 264
2025
Q1 		$93.4M Buy
1,041,000
+659,100
+173% +$61.5M 0.11% 237
2024
Q4 		$38M Sell
381,900
-26,500
-6% -$2.73M 0.05% 478
2024
Q3 		$46.4M Buy
408,400
+334,200
+450% +$39.7M 0.07% 369
2024
Q2 		$9.19M Sell
74,200
-52,500
-41% -$6.76M 0.01% 957
2024
Q1 		$16.7M Sell
126,700
-161,200
-56% -$19.9M 0.03% 630
2023
Q4 		$31.4M Buy
287,900
+60,900
+27% +$6.32M 0.06% 389
2023
Q3 		$23.4M Buy
227,000
+147,100
+184% +$15.9M 0.06% 369
2023
Q2 		$9.22M Buy
+79,900
New +$9.07M 0.03% 556

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Qube Research & Technologies (QRT)'s MRK Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Merck (MRK) in Q4 2025, closing a stake of 2,063,967 shares — an estimated $194M sold.

Qube Research & Technologies (QRT) first reported a position in MRK in Q1 2018 and held it in 26 quarters. The position peaked at $529M in Q2 2024. 3,651 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 2,063,967 Merck shares in Q4 2025, an estimated $194M.
  • Qube Research & Technologies (QRT) first reported a position in Merck in Q1 2018 and held it in 26 quarters.
  • Qube Research & Technologies (QRT)'s Merck position peaked at $529M in Q2 2024.
  • 3,651 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.